News – Page 443 – Endpoints News

Prelude to buyout? Astellas picks up Taysha stock, two gene therapy programs for $50M

3 years ago

FDA inspection at Catalent’s Belgium facility uncovers data, equipment and other QC issues

3 years ago

J&J uncorks new Tremfya data in ulcerative colitis as its rival awaits an FDA decision

3 years ago

Pharma lobbying headed for record-breaking 2022, nonprofit says

3 years ago

Regeneron, Bayer's Eylea nabs six months of pediatric exclusivity as competition waits to enter the market

3 years ago

Genentech's newest ad campaign calls out the systemic racism fueling US health inequities

3 years ago

Developing gene therapies for neurodegenerative diseases: FDA finalizes guidance

3 years ago

Pfizer to make an almost $1B investment in its Dublin manufacturing facility — report

3 years ago

Recent use of Pfizer's Covid pill declines sharply compared to this summer

3 years ago

In $23M deal, Syncona adds ex-Biogen partner and 20-year-old gene therapy outfit AGTC to portfolio

3 years ago

Tricida bet its future on one last readout for its CKD drug. Now that’s all but gone

3 years ago

A Texas-Illinois cancer biotech searches for more Series B capital two years after extension

3 years ago

As top investor makes its play to grab lead drug, PhaseBio counters with Chapter 11, stalking-horse bid

3 years ago

After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win

3 years ago

The namesake behind Harvard’s Wyss Institute has made his fourth donation, this time to the tune of $350M

3 years ago

CD28 kills again? Mitch Gold’s plan to make cell therapy 2.0 history crashes after another patient dies of ...

3 years ago

Novartis takes another stride toward Alexion's turf with PhIII PNH win

3 years ago

Sumitomo clinches Myovant buyout after upping offer to $2.9B

3 years ago

Updated: After long slog, AstraZeneca finally gets CTLA-4 drug over finish line

3 years ago

Eli Lilly, AbbVie in M&A action; Gilead’s oncology deal spree; FDA puts its foot down on Makena; and more

3 years ago

Roche issues voluntary recall for Susvimo over manufacturing issue

3 years ago

Will feds reclassify 'magic mushroom' therapies? Seattle doctor ramps up court battle

3 years ago

Haleon draws attention to unpaid sick days and lost wages in Theraflu campaign

3 years ago

Rise 'til we fall: Pharma ad spending still on the way up, even as most other categories drop

3 years ago

First page Previous page 440 441 442443444 445 446 Next page Last page